Cargando…
Plasma Trimethylamine-N-oxide and impaired glucose regulation: Results from The Oral Infections, Glucose Intolerance and Insulin Resistance Study (ORIGINS)
Trimethylamine-N-oxide (TMAO)–a gut-microbiota metabolite–is a biomarker of cardiometabolic risk. No studies have investigated TMAO as an early biomarker of longitudinal glucose increase or prevalent impaired glucose regulation. In a longitudinal cohort study, 300 diabetes-free men and women (77%) a...
Autores principales: | Roy, Sumith, Yuzefpolskaya, Melana, Nandakumar, Renu, Colombo, Paolo C., Demmer, Ryan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961885/ https://www.ncbi.nlm.nih.gov/pubmed/31940332 http://dx.doi.org/10.1371/journal.pone.0227482 |
Ejemplares similares
-
Impaired glucose regulation, SARS-CoV-2 infections and adverse COVID-19 outcomes
por: Roy, Sumith, et al.
Publicado: (2022) -
Early microbial markers of periodontal and cardiometabolic diseases in ORIGINS
por: Marotz, Clarisse, et al.
Publicado: (2022) -
Nitrite Generating and Depleting Capacity of the Oral Microbiome and Cardiometabolic Risk: Results from ORIGINS
por: Goh, Charlene E., et al.
Publicado: (2022) -
Glucose Intolerance, Plasma Insulin Levels, and Colon Adenomas in Japanese Men
por: Nishii, Takasei, et al.
Publicado: (2001) -
Blueberries’ Impact on Insulin Resistance and Glucose Intolerance
por: Stull, April J.
Publicado: (2016)